What's new

Medicines Developed by DRDO

Hindustani78

BANNED
Joined
Apr 8, 2014
Messages
40,471
Reaction score
-47
Country
India
Location
India
Ministry of Defence
03-February, 2017 16:13 IST
Medicines Developed by DRDO

Defence Research and Development Establishment (DRDE), a Gwalior based laboratory of Defence Research and Development Organisation (DRDO) has developed the following medicines and medical equipment:-

Medicines:

• Monoisoamyl dimcracaptosuccinic acid (miDMSA) as a treatment for chronic arsenic poisoning.

• Alpha-ketoglutarate (A-KG) as an antidote for cyanide poisoning.

• 2-deoxiglucose (2-DG) as radio-modifier and cancer therapy.

Medical kits/Equipment:

• First Aid Kit Chemical Warfare (CW) Type A (for 03 persons).

• First Aid Kit CW Type B (for 30 persons) specially for field hospitals.

• Auto injector for on-field application of medicaments for treating Nerve Agent poisoning.

These Medicines and Medical Kits/ Equipment are very specific for Services for use during Nuclear, Biological & Chemical (NBC) warfare scenario. Therefore, these have not been brought out in the open market.

However, DRDO developed herbal medicine “Lucoskin ointment and syrup” for treatment of Lucoderma has already been in the market since 2011.

This information was given by Minister of State for Defence Dr. Subhash Bhamre in a written reply to Shri Godse Hemant Tukaram in Lok Sabha today.

***
 
.
Ministry of Defence
15-December, 2017 11:27 IST
Society for Nuclear Medicine International Conference (SNMICON)

Raksha Rajya Mantri Dr. Subash Bhamre inaugurated a four day 49th Annual Conference of the Society of Nuclear Medicine – India SNMICON, here today.

Dr. Bhamre said that advances in medical science have led to significant improvements in our quality of life. Increase in life expectancy, cure of hitherto incurable diseases and the ability to understand the human body can all be attributed to these advancements. He also added that the role of nuclear medicine has gained significant momentum over the past few years.

He said a dedicated research laboratory of DRDO Life Cluster, Institute of Nuclear Medicine and Allied Sciences (INMAS) is making considerable contribution in the research of nuclear medicine, thereby exemplifying the peaceful use of nuclear energy. INMAS has always taken a lead with academic developments in the areas of radiation and imaging sciences. The contributions of INMAS are a clear example of how research supported by the Ministry of Defence has significant benefits for society at large.

Dr. Bhamre informed that, scientists of INMAS are active members for various SNM activities, be it educational programmes, policy drafting or training activities. He called for furthering the close association of INMAS with SNM, hospitals and national universities along with industries and private players to advance nuclear medicine’s diagnostic and therapeutic applications through research and training.

President, Society of Nuclear Medicine (India) Dr. Anshu Rajneesh Sharma, Director, All India Institute of Medical Sciences (AIIMS), Delhi Prof (Dr.) Randeep Guleria and others also spoke on the occasion.

*************

The Minister of State for Defence, Dr. Subhash Ramrao Bhamre lighting the lamp to inaugurate the 49th Annual Conference of the Society of Nuclear Medicine India, in New Delhi on December 14, 2017.
s20171215119427.jpg


The Minister of State for Defence, Dr. Subhash Ramrao Bhamre releasing a souvenir at the inauguration of the 49th Annual Conference of the Society of Nuclear Medicine India, in New Delhi on December 14, 2017. The DS & Director General- Life Science, DRDO, Dr. Shashi Bala Singh and the President, Society of Nuclear Medicine (India), Dr. Anshu Rajnish are also seen.
s20171215119428.jpg


The Minister of State for Defence, Dr. Subhash Ramrao Bhamre addressing the 49th Annual Conference of the Society of Nuclear Medicine India, in New Delhi on December 14, 2017.
s20171215119429.jpg
 
Last edited:
.
Back
Top Bottom